Regan L M, Stearns-Kurosawa D J, Kurosawa S, Mollica J, Fukudome K, Esmon C T
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, USA.
J Biol Chem. 1996 Jul 19;271(29):17499-503. doi: 10.1074/jbc.271.29.17499.
A soluble form of the endothelial cell protein C receptor (EPCR) was analyzed for the ability to modulate the functional properties of protein C and activated protein C (APC). In a plasma clotting system initiated with factor Xa, EPCR blocked the anticoagulant activity of APC in a dose-dependent fashion. EPCR had no influence on clotting in the absence of APC. Consistent with the plasma results, EPCR slowed the proteolytic inactivation of factor Va by slowing both of the key proteolytic cleavages in the heavy chain of factor Va. EPCR did not prevent protein C activation by the soluble thrombin-thrombomodulin complex, did not alter the inactivation of APC by alpha1-antitrypsin or protein C inhibitor, and did not influence the kinetics of peptide paranitroanilide substrate cleavage significantly. We conclude that EPCR binds to an exosite on APC that selectively modulates the enzyme specificity in a manner reminiscent of the influence of thrombomodulin on thrombin.
对内皮细胞蛋白C受体(EPCR)的一种可溶性形式进行了分析,以研究其调节蛋白C和活化蛋白C(APC)功能特性的能力。在由因子Xa启动的血浆凝血系统中,EPCR以剂量依赖性方式阻断APC的抗凝活性。在没有APC的情况下,EPCR对凝血没有影响。与血浆结果一致,EPCR通过减缓因子Va重链中的两个关键蛋白水解切割,减缓了因子Va的蛋白水解失活。EPCR不阻止可溶性凝血酶-血栓调节蛋白复合物对蛋白C的激活,不改变α1-抗胰蛋白酶或蛋白C抑制剂对APC的失活作用,并且对肽对硝基苯胺底物切割的动力学没有显著影响。我们得出结论,EPCR与APC上的一个外位点结合,该位点以类似于血栓调节蛋白对凝血酶的影响方式选择性地调节酶的特异性。